Drug:
Reaction: MYELOSUPPRESSION
20250101 - 20251231
No. 701 - 800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 701 | 25018217 |
JP |
8 | 1 |
Myelosuppression, |
||||
PEMBROLIZUMAB, CISPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
| 702 | 25018271 |
JP |
2 | |
Ascites, Myelosuppression, Drug level decreased, |
||||
| 703 | 25018286 |
CN |
65 | 2 |
Myelosuppression, |
||||
EXEMESTANE, ABEMACICLIB, |
||||
| 704 | 25019108 |
CN |
63 | 1 |
Myelosuppression, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SELINEXOR, SELINEXOR, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, LENALIDOMIDE, LENALIDOMIDE, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, OLANZAPINE, |
||||
| 705 | 25019121 |
CN |
2 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 706 | 25019124 |
CN |
56 | 2 |
White blood cell count decreased, Neutrophil count decreased, Myelosuppression, Dizziness, Asthenia, Pyrexia, |
||||
EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE, TRASTUZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 707 | 25019343 |
CN |
49 | 2 |
Myelosuppression, Platelet count decreased, |
||||
RIBOCICLIB, |
||||
| 708 | 25019530 |
CN |
73 | 1 |
Myelosuppression, |
||||
FRUQUINTINIB, |
||||
| 709 | 25019564 |
CN |
43 | 2 |
Gastrointestinal disorder, Nausea, Vomiting, Myelosuppression, Haemoglobin decreased, White blood cell count decreased, Neutrophil count decreased, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 710 | 25019601 |
CN |
60 | 2 |
Myelosuppression, |
||||
| 711 | 25020079 |
US |
1 | |
Multiple organ dysfunction syndrome, Myelosuppression, Hepatic failure, Bacterial sepsis, Anaemia, Gait disturbance, Muscle atrophy, Loss of consciousness, Yellow skin, Erythema, Fungal infection, |
||||
EMPAGLIFLOZIN, |
||||
| 712 | 25020950 |
CN |
52 | |
Myelosuppression, Hepatic function abnormal, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, |
||||
| 713 | 25011139 |
CN |
70 | |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL, PACLITAXEL, |
||||
| 714 | 25011359 |
CN |
71 | 2 |
Myelosuppression, |
||||
DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 715 | 25011434 |
CN |
39 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, |
||||
| 716 | 25011442 |
CN |
62 | 2 |
Myelosuppression, Pyrexia, |
||||
TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, |
||||
| 717 | 25011483 |
CN |
66 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, PACLITAXEL, PACLITAXEL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 718 | 25012132 |
JP |
5 | 2 |
Haematochezia, Condition aggravated, Small intestinal haemorrhage, Anaemia, Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, IFOSFAMIDE, ETOPOSIDE, IFOSFAMIDE, |
||||
| 719 | 25012494 |
CN |
60 | 2 |
Myelosuppression, |
||||
RITUXIMAB, EPIRUBICIN HYDROCHLORIDE, VINCRISTINE SULFATE, |
||||
| 720 | 25012562 |
JP |
61 | |
Myelosuppression, |
||||
PEMBROLIZUMAB, |
||||
| 721 | 25012695 |
CN |
||
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, PACLITAXEL, PACLITAXEL, PACLITAXEL, |
||||
| 722 | 25012841 |
US |
4 | 2 |
Myelosuppression, Pancytopenia, Septic shock, Pneumonia, Drug ineffective, Folliculitis, |
||||
METHIMAZOLE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, CYCLOSPORINE, CYCLOSPORINE, CHOLESTYRAMINE, CHOLESTYRAMINE, ROMIPLOSTIM, ROMIPLOSTIM, ELTROMBOPAG, ELTROMBOPAG, |
||||
| 723 | 25013023 |
DE |
55 | 1 |
Myelosuppression, Rebound effect, Hepatitis acute, Drug ineffective, Gastrointestinal toxicity, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, DURVALUMAB, DURVALUMAB, DURVALUMAB, DURVALUMAB, |
||||
| 724 | 25013269 |
AU |
56 | 2 |
Cytopenia, Febrile neutropenia, Myelosuppression, Neutropenic sepsis, Pancytopenia, Thrombocytopenia, Anaemia, |
||||
AZACITIDINE, AZACITIDINE FOR, CISPLATIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOCETAXEL, DOCETAXEL ANHYDROUS, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, EPIRUBICIN HYDROCHLORIDE, FLUOROURACIL, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 725 | 25013491 |
FR |
74 | 1 |
Tubulointerstitial nephritis, Acute kidney injury, Myelosuppression, Asthenia, Dyspnoea, Hypomagnesaemia, |
||||
HYDROXYUREA, RAMIPRIL, HYDROCHLOROTHIAZIDE, NICARDIPINE HYDROCHLORIDE, NICARDIPINE, |
||||
| 726 | 25013876 |
CN |
70 | 1 |
Myelosuppression, Oropharyngeal pain, Pyrexia, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 727 | 25014117 |
CN |
75 | 1 |
Myelosuppression, |
||||
PEMETREXED, PEMETREXED DISODIUM, |
||||
| 728 | 25014153 |
CN |
40 | 1 |
Myelosuppression, |
||||
EXEMESTANE, RIBOCICLIB, |
||||
| 729 | 25014183 |
CN |
60 | 2 |
Myelosuppression, Cytopenia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DEXTROSE MONOHYDRATE, EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE, PACLITAXEL, PACLITAXEL, PACLITAXEL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 730 | 25014245 |
CN |
71 | 2 |
Myelosuppression, White blood cell count decreased, Platelet count decreased, |
||||
RIBOCICLIB, |
||||
| 731 | 25014358 |
CN |
7 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, VINCRISTINE SULFATE, |
||||
| 732 | 25014502 |
CN |
||
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CARBOPLATIN, CARBOPLATIN, |
||||
| 733 | 25014706 |
JP |
6 | 2 |
Immune-mediated dermatitis, Myelosuppression, |
||||
PEMBROLIZUMAB, CISPLATIN, |
||||
| 734 | 25014838 |
FR |
62 | 2 |
Bone marrow oedema syndrome, Arthralgia, Movement disorder, Bone marrow oedema, Osteopenia, Epiphyseal disorder, Myelosuppression, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, OXALIPLATIN, OXALIPLATIN, FLUOROURACIL, FLUOROURACIL, |
||||
| 735 | 25015080 |
CN |
47 | 2 |
Myelosuppression, |
||||
CAPECITABINE, |
||||
| 736 | 25015081 |
CN |
45 | 2 |
Myelosuppression, Pyrexia, |
||||
| 737 | 25015389 |
CN |
26 | 1 |
Myelosuppression, Rash, |
||||
RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, CYTARABINE, TRANEXAMIC ACID, |
||||
| 738 | 25006815 |
CN |
49 | |
Myelosuppression, |
||||
THIOTEPA, THIOTEPA, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 739 | 25007389 |
CN |
61 | |
Myelosuppression, |
||||
DURVALUMAB, GEMCITABINE HYDROCHLORIDE, CISPLATIN, |
||||
| 740 | 25007594 |
US |
||
Myelosuppression, Nephropathy toxic, Dry mouth, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 741 | 25007793 |
CN |
56 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, |
||||
| 742 | 25007845 |
CN |
49 | 2 |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, Haemoglobin decreased, Platelet count decreased, Pyrexia, |
||||
RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, EPIRUBICIN HYDROCHLORIDE, VINCRISTINE SULFATE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 743 | 25008079 |
US |
1 | |
Myelosuppression, |
||||
FLUCONAZOLE, ACYCLOVIR, |
||||
| 744 | 25008128 |
CN |
||
Myelosuppression, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 745 | 25008441 |
PK |
39 | 2 |
Pulmonary thrombosis, Myelosuppression, |
||||
AZATHIOPRINE, AZATHIOPRINE, |
||||
| 746 | 25008453 |
NL |
5 | 1 |
Drug ineffective, Myelosuppression, |
||||
METHOTREXATE, METHOTREXATE SODIUM, INFLIXIMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, METHYLPREDNISOLONE, METHYLPREDNISOLONE, |
||||
| 747 | 25008951 |
CN |
34 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 748 | 25009508 |
BR |
62 | 2 |
Osteonecrosis of jaw, Myelosuppression, Gastrointestinal candidiasis, Thrombocytopenia, Hypokalaemia, Stomatitis, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, TRASTUZUMAB, TRASTUZUMAB, |
||||
| 749 | 25009562 |
CN |
68 | 2 |
Hyponatraemia, Myelosuppression, Therapeutic response decreased, |
||||
CISPLATIN, CISPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
| 750 | 25009955 |
CN |
70 | 2 |
Myelosuppression, |
||||
DARATUMUMAB, CARFILZOMIB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 751 | 25010167 |
CN |
11 | 1 |
Myelosuppression, Hepatic enzyme increased, Protein total decreased, Blood albumin decreased, |
||||
CYTARABINE, CYTARABINE, MERCAPTOPURINE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 752 | 25010174 |
CN |
75 | 2 |
Myelosuppression, |
||||
PALBOCICLIB, EXEMESTANE, |
||||
| 753 | 25010250 |
CN |
65 | 2 |
Myelosuppression, |
||||
ABEMACICLIB, |
||||
| 754 | 25010384 |
BR |
62 | 2 |
Osteonecrosis of jaw, Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, |
||||
| 755 | 25010482 |
CN |
60 | 2 |
Hyponatraemia, Myelosuppression, Hypothyroidism, |
||||
PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, |
||||
| 756 | 25010700 |
CN |
67 | |
Myelosuppression, |
||||
| 757 | 25010718 |
CN |
54 | 2 |
Myelosuppression, Product use in unapproved indication, Vomiting, Hypertension, |
||||
PEMBROLIZUMAB, PEMETREXED, PEMETREXED DISODIUM, CISPLATIN, |
||||
| 758 | 25010738 |
CN |
58 | 1 |
Myelosuppression, |
||||
CETUXIMAB, IRINOTECAN HYDROCHLORIDE, FLUOROURACIL, LEUCOVORIN CALCIUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 759 | 25010844 |
CN |
73 | |
Myelosuppression, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 760 | 25010851 |
CN |
70 | |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 761 | 25010889 |
CN |
68 | |
Myelosuppression, Diabetes mellitus, Liver injury, |
||||
PACLITAXEL, PACLITAXEL, PACLITAXEL, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, |
||||
| 762 | 25001718 |
CN |
69 | |
Myelosuppression, |
||||
| 763 | 25002342 |
CN |
66 | |
Myelosuppression, Chest discomfort, Dyspnoea, |
||||
| 764 | 25002484 |
CN |
70 | 1 |
Myelosuppression, |
||||
TRASTUZUMAB, CAPECITABINE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 765 | 25002547 |
CN |
55 | 1 |
Myelosuppression, |
||||
FRUQUINTINIB, |
||||
| 766 | 25002584 |
CN |
78 | 2 |
Myelosuppression, |
||||
BEVACIZUMAB, CAPECITABINE, |
||||
| 767 | 25002919 |
CN |
62 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, PACLITAXEL, CAPECITABINE, |
||||
| 768 | 25002980 |
US |
6 | 1 |
Myelosuppression, |
||||
SULFAMETHOXAZOLE AND TRIMETHOPRIM, ACYCLOVIR, FLUCONAZOLE, |
||||
| 769 | 25003241 |
CA |
43 | 1 |
Acute kidney injury, Myelosuppression, Drug ineffective, |
||||
HUMAN IMMUNOGLOBULIN G, FOSCARNET SODIUM, GANCICLOVIR SODIUM, GANCICLOVIR, GANCICLOVIR SODIUM, GANCICLOVIR, |
||||
| 770 | 25003259 |
CN |
54 | 2 |
Myelosuppression, Gastrointestinal disorder, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 771 | 25003288 |
CN |
68 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, PERTUZUMAB, |
||||
| 772 | 25003354 |
CN |
61 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, TRASTUZUMAB, PACLITAXEL, CARBOPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 773 | 25003391 |
CN |
58 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 774 | 25003497 |
CN |
43 | 2 |
Myelosuppression, Hypothyroidism, Abdominal pain, Hepatic function abnormal, |
||||
| 775 | 25003580 |
CN |
61 | 2 |
Myelosuppression, White blood cell count decreased, |
||||
PAZOPANIB, PAZOPANIB HYDROCHLORIDE, |
||||
| 776 | 25004582 |
CN |
35 | 2 |
Myelosuppression, |
||||
| 777 | 25004674 |
CN |
53 | 2 |
Liver abscess, Myelosuppression, COVID-19, Gastrointestinal disorder, Hepatic enzyme increased, Off label use, |
||||
IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE, FLUOROURACIL, FLUOROURACIL, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, OXALIPLATIN, OXALIPLATIN, |
||||
| 778 | 25004753 |
BR |
62 | 2 |
Osteonecrosis of jaw, Oesophageal candidiasis, Hypokalaemia, Myelosuppression, Thrombocytopenia, Product use in unapproved indication, |
||||
CARBOPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 779 | 25004810 |
CN |
53 | 2 |
Reactive capillary endothelial proliferation, Myelosuppression, Gastrointestinal disorder, Hepatic enzyme increased, Hypothyroidism, |
||||
IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE, FLUOROURACIL, FLUOROURACIL, FLUOROURACIL, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, |
||||
| 780 | 25005030 |
CN |
46 | 2 |
Myelosuppression, Gamma-glutamyltransferase increased, |
||||
| 781 | 25005300 |
CN |
61 | 2 |
Myelosuppression, |
||||
| 782 | 25005346 |
CN |
63 | 2 |
Myelosuppression, |
||||
DARATUMUMAB, |
||||
| 783 | 25005674 |
CN |
56 | 2 |
Myelosuppression, Productive cough, Fatigue, |
||||
ABEMACICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 784 | 25005884 |
CN |
43 | 2 |
Myelosuppression, |
||||
PEMETREXED, PEMETREXED DISODIUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, BEVACIZUMAB, |
||||
| 785 | 25005957 |
CN |
62 | 2 |
Myelosuppression, |
||||
PEMBROLIZUMAB, PACLITAXEL, CARBOPLATIN, |
||||
| 786 | 25006092 |
CN |
58 | 2 |
Myelosuppression, |
||||
CETUXIMAB, OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, |
||||
| 787 | 25006302 |
CN |
70 | |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL, CARBOPLATIN, CARBOPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 788 | 25006332 |
CN |
75 | |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL, CARBOPLATIN, CARBOPLATIN, |
||||
| 789 | 25001380 |
CN |
61 | 2 |
Myelosuppression, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 790 | 25001406 |
CN |
62 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 791 | 25001530 |
CN |
33 | |
Myelosuppression, |
||||
| 792 | 25001533 |
CN |
69 | |
Immune-mediated cystitis, Myelosuppression, |
||||
| 793 | 25001538 |
CN |
80 | 1 |
Myelosuppression, Full blood count decreased, |
||||
VENETOCLAX, |
||||
| 794 | 25001540 |
CN |
56 | |
Myelosuppression, |
||||
ZANUBRUTINIB, ZANUBRUTINIB, ZANUBRUTINIB, ZANUBRUTINIB, LENALIDOMIDE, LENALIDOMIDE, |
||||
| 795 | 25001550 |
CN |
54 | |
Myelosuppression, |
||||
| 796 | 25001558 |
CN |
76 | 1 |
Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 797 | 25001597 |
CN |
71 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, PACLITAXEL, PACLITAXEL, |
||||
| 798 | 25001600 |
CN |
68 | |
Myelosuppression, |
||||
| 799 | 24997328 |
CN |
56 | |
Myelosuppression, |
||||
OLAPARIB, OLAPARIB, BEVACIZUMAB, BEVACIZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 800 | 24997462 |
CN |
66 | 2 |
Myelosuppression, |
||||
BEVACIZUMAB, PACLITAXEL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28